Corroborating these findings, our research establishes that inhibiting LDHA impedes mTOR activation and restricts cancer cell proliferation, particularly in ALDH-active endometrial cancer spheroids, regardless of K-Ras genomic aberrations (Fig. 6). The gene discussed is LDHA; the disease is endometrial cancer.